[Influence of the antihypoxantic therapy on children with generalized peritonitis]

V A Zavyalkin1, M A Barskaya1, A V Varlamov2

  • 1Samara State Medical University, Ministry of Health of Russia.

Khirurgiia
|January 17, 2017
PubMed

Insights

Optimized fluid therapy using reamberin and remaxol improved treatment outcomes for pediatric purulent peritonitis. This approach reduced intoxication and inflammation, with long-term benefits for vascular health.

Area of Science:

  • Pediatric Surgery
  • Critical Care Medicine
  • Pharmacology

Background:

  • Widespread purulent peritonitis in children presents significant treatment challenges.
  • Optimizing fluid therapy is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of combined fluid therapy with reamberin and remaxol for pediatric purulent peritonitis.
  • To assess the impact of this optimized therapy on clinical recovery and long-term vascular health.

Main Methods:

  • A study of 269 children (aged 1-15) with purulent peritonitis.
  • Comparison of optimized infusion therapy (reamberin alone vs. reamberin and remaxol) alongside laparoscopic surgery.
  • Monitoring of inflammatory markers, liver function, and intima-media thickness.

Main Results:

  • The combined therapy group showed faster resolution of intoxication symptoms (leukocytosis, fever).
  • Improved recovery of liver protein synthesis and reduced inflammatory syndromes were observed.
  • The subgroup receiving reamberin and remaxol demonstrated the most significant improvements.

Conclusions:

  • Combined infusion therapy with reamberin and remaxol enhances purulent peritonitis treatment in children.
  • Long-term follow-up revealed endothelial dysfunction in children post-peritonitis.
  • Clinical recommendations aim to mitigate endothelial dysfunction and prevent future vascular pathology.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
696
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K